title: Breast cancer amplified sequence 2, a novel negative regulator of the p53 tumor suppressor.
abstract: Breast cancer amplified sequence 2 (BCAS2) was reported previously as a transcriptional coactivator of estrogen receptor. Here, we report that BCAS2 directly interacts with p53 to reduce p53 transcriptional activity by mildly but consistently decreasing p53 protein in the absence of DNA damage. However, in the presence of DNA damage, BCAS2 prominently reduces p53 protein and provides protection against chemotherapeutic agent such as doxorubicin. Deprivation of BCAS2 induces apoptosis in p53 wild-type cells but causes G(2)-M arrest in p53-null or p53 mutant cells. There are at least two apoptosis mechanisms induced by silencing BCAS2 in wild-type p53-containing cells. Firstly, it increases p53 retention in nucleus that triggers the expression of apoptosis-related genes. Secondly, it increases p53 transcriptional activity by raising p53 phosphorylation at Ser(46) and decreases p53 protein degradation by reducing p53 phosphorylation at Ser(315). We show for the first time that BCAS2, a small nuclear protein (26 kDa), is a novel negative regulator of p53 and hence a potential molecular target for cancer therapy.
authors.affiliation: Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
authors.forename: Ping-Chang
authors.initials: PC
authors.lastname: Kuo
authors.forename: Yeou-Ping
authors.initials: YP
authors.lastname: Tsao
authors.forename: Hung-Wei
authors.initials: HW
authors.lastname: Chang
authors.forename: Po-Han
authors.initials: PH
authors.lastname: Chen
authors.forename: Chu-Wei
authors.initials: CW
authors.lastname: Huang
authors.forename: Shinn-Tsuen
authors.initials: ST
authors.lastname: Lin
authors.forename: Yu-Tzu
authors.initials: YT
authors.lastname: Weng
authors.forename: Tzung-Chieh
authors.initials: TC
authors.lastname: Tsai
authors.forename: Sheau-Yann
authors.initials: SY
authors.lastname: Shieh
authors.forename: Show-Li
authors.initials: SL
authors.lastname: Chen
mesh_terms: D017209:Apoptosis / Q000502:physiology; D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D048708:Cell Growth Processes / Q000502:physiology; D045744:Cell Line, Tumor; D002467:Cell Nucleus / Q000378:metabolism; D004249:DNA Damage; D006801:Humans; D009363:Neoplasm Proteins / Q000096:biosynthesis / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D011485:Protein Binding; D011499:Protein Processing, Post-Translational; D017434:Protein Structure, Tertiary; D015533:Transcriptional Activation; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*
chemical_list: C120624:BCAS2 protein, human; D009363:Neoplasm Proteins; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53